PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11502794-9 2001 This was substantiated further with the findings that increasing intracellular cAMP using forskolin or (Bu)2cAMP inhibited basal extravillous trophoblast cell migration and blocked IGF-II stimulation of migration. Cyclic AMP 79-83 insulin like growth factor 2 Homo sapiens 181-187 22341662-6 2012 Here, we review approaches that boost memories by targeting the cAMP response element binding protein-CCAAT enhancer binding protein (CREB-C/EBP) pathway and/or its recently identified target gene insulin-like growth factor 2 (IGF2). Cyclic AMP 64-68 insulin like growth factor 2 Homo sapiens 197-225 22341662-6 2012 Here, we review approaches that boost memories by targeting the cAMP response element binding protein-CCAAT enhancer binding protein (CREB-C/EBP) pathway and/or its recently identified target gene insulin-like growth factor 2 (IGF2). Cyclic AMP 64-68 insulin like growth factor 2 Homo sapiens 227-231 1337056-7 1992 Treatment with 100 ng/ml IGF-II produced a significant increase in the basal accumulation of cyclic AMP in porcine granulosa cells. Cyclic AMP 93-103 insulin like growth factor 2 Homo sapiens 25-31 7544271-2 1995 We, therefore, investigated the effect of recombinant human IGF-II on cortisol and cAMP synthesis from adult bovine adrenocortical cells. Cyclic AMP 83-87 insulin like growth factor 2 Homo sapiens 60-66 8206319-4 1994 On the contrary, pretreatment with IGF-II for 10 min enhanced the cAMP production stimulated by bradykinin (10 nM, 3 min) by 2.5-fold whereas no additive effects of IGF-II on the increased ligand binding to the mannose 6-phosphate/IGF-II receptor in response to bradykinin were observed. Cyclic AMP 66-70 insulin like growth factor 2 Homo sapiens 35-41 8206319-5 1994 These results indicate that in fibroblasts the rapid IGF-II-induced redistribution of mannose 6-phosphate/IGF-II receptors is not mediated by inositol trisphosphate, diacylglycerol or cAMP, but that IGF-II may modulate permissively other agonist-generated signals. Cyclic AMP 184-188 insulin like growth factor 2 Homo sapiens 53-59 8404598-8 1993 IGF-I and the related growth factors, insulin and IGF-II, inhibited PTH-stimulated cAMP production with a rank order of potency of IGF-I > or = IGF-II > insulin, indicating that the actions of IGF-I on SaOS-2 cells were probably mediated by the IGF-I receptor. Cyclic AMP 83-87 insulin like growth factor 2 Homo sapiens 50-56 8404598-8 1993 IGF-I and the related growth factors, insulin and IGF-II, inhibited PTH-stimulated cAMP production with a rank order of potency of IGF-I > or = IGF-II > insulin, indicating that the actions of IGF-I on SaOS-2 cells were probably mediated by the IGF-I receptor. Cyclic AMP 83-87 insulin like growth factor 2 Homo sapiens 147-153 9141522-8 1997 IGF-II (100 ng/mL) significantly (P < 0.001) increased ACTH-, forskolin-, and cAMP-stimulated production of cortisol by 2.4-, 4.3-, and 3.2-fold, respectively, and that of DHEA-S by 1.4, 1.6-, and 1.4-fold, respectively. Cyclic AMP 81-85 insulin like growth factor 2 Homo sapiens 0-6 9141522-9 1997 IGF-I (100 ng/mL) had similar effects as IGF-II and significantly (P < 0.001) increased ACTH-, forskolin-, and cAMP-stimulated production of cortisol by 2.8-, 3.9-, and 3.1-fold, respectively, and that of DHEA-S by 1.3-, 1.6-, and 1.4-fold, respectively. Cyclic AMP 114-118 insulin like growth factor 2 Homo sapiens 41-47 7493951-3 1995 In cells transfected with IGF-IIR cDNA, IGF-II decreased cAMP accumulation promoted by cholera toxin or forskolin. Cyclic AMP 57-61 insulin like growth factor 2 Homo sapiens 26-32 8206319-0 1994 Effects of insulin-like growth factor II on the generation of inositol trisphosphate, diacylglycerol and cAMP in human fibroblasts. Cyclic AMP 105-109 insulin like growth factor 2 Homo sapiens 11-40 7689570-10 1993 These observations suggest that the differential regulation of cell proliferation by the cAMP signal transduction pathway may be mediated, at least in part, by the IGF-II regulatory system. Cyclic AMP 89-93 insulin like growth factor 2 Homo sapiens 164-170 7852883-8 1993 IGF-II mRNA was also under cyclic AMP-dependent regulation (threefold increase; P = 0.025). Cyclic AMP 27-37 insulin like growth factor 2 Homo sapiens 0-6 1337056-10 1992 Our findings suggest that IGF-II may be a general stimulator in the proliferation and differentiation of granulosa cells, and that cyclic AMP may be a second messenger for the effects of IGF-II in ovarian granulosa cells. Cyclic AMP 131-141 insulin like growth factor 2 Homo sapiens 187-193 3349907-8 1988 This suggests that the IGF-II gene is regulated differently in fetal testes than it is in fetal adrenals, placenta, or adult granulosa cells, where we have previously shown that ACTH, cAMP, and gonadotropins, respectively, increase IGF-II mRNA accumulation (Proc. Cyclic AMP 184-188 insulin like growth factor 2 Homo sapiens 23-29 1726835-0 1991 Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system. Cyclic AMP 93-97 insulin like growth factor 2 Homo sapiens 151-157 31554266-7 2019 In conclusion, ketamine promotes the proliferation of NPCs presumably by involving cAMP-IGF2 signaling. Cyclic AMP 83-87 insulin like growth factor 2 Homo sapiens 88-92 3031644-5 1987 In cultured human fetal adrenal cells, ACTH and dibutyryl cAMP increased IGF-II mRNA accumulation, but human chorionic gonadotropin and angiotensin II did not. Cyclic AMP 58-62 insulin like growth factor 2 Homo sapiens 73-79 3031644-7 1987 Dibutyryl cAMP also increased IGF-II mRNA accumulation in cultured human placental cells. Cyclic AMP 10-14 insulin like growth factor 2 Homo sapiens 30-36 3031644-10 1987 The data indicate that the IGF-II gene is expressed in human steroidogenic tissues and is regulated by cAMP. Cyclic AMP 103-107 insulin like growth factor 2 Homo sapiens 27-33 3031644-4 1987 In cultured human ovarian granulosa cells, follicle-stimulating hormone, human chorionic gonadotropin, and dibutyryl cAMP increased IGF-II mRNA, but corticotropin [adrenocorticotropic hormone (ACTH)], chorionic somatomammotropin, growth hormone, prolactin, dexamethasone, estradiol, and progesterone had no effect. Cyclic AMP 117-121 insulin like growth factor 2 Homo sapiens 132-138 31588501-11 2020 G+B potentiated IGF2 stimulation by cAMP. Cyclic AMP 36-40 insulin like growth factor 2 Homo sapiens 16-20 30541132-10 2019 GB treatment potentiated cAMP stimulation of aromatase and IGF2 stimulation by FSH. Cyclic AMP 25-29 insulin like growth factor 2 Homo sapiens 59-63